Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What is the Predicted Annual Growth Rate of the Mitral Valve Disease Market Over the Coming Decade?

The market size for mitral valve disease has witnessed robust growth in the past few years. There’s anticipated growth from $3 billion in 2024 to $3.3 billion in 2025, reflecting a compound annual growth rate (CAGR) of 9.8%. The notable growth during the historical period is linked with initiatives to educate patients, suitable reimbursement policies with insurance coverage, increased spending on healthcare, a surge in awareness and screening measures, and a growing market presence.

Expectations are set for the mitral valve disease market to experience significant expansion in the upcoming years. It’s projected to burgeon to $4.73 billion by 2029, with an anticipated compound annual growth rate (CAGR) of 9.4%. Underlying causes for this predicted progress during the forecast period are higher instances of mitral valve disease, surging acceptance of minimally invasive methods, remarkable strides in heart valve surgery technology, significant venture capital funding, and boosted manufacturer interest. Some of the major trends in the forecast period will be enhanced technology, improvements in transcatheter technologies, in addition to the ongoing technological evolutions within surgical procedures.

What External and Internal Drivers Are Contributing to the Growth of the Mitral Valve Disease Market’s Growth?

The growing incidence of vascular heart diseases is anticipated to fuel the expansion of the mitral valve disease market. Vascular heart diseases comprise a series of conditions that impact the blood vessels that provide blood to the heart or those within the heart. This upward trend in vascular heart disease cases is caused by the complex interaction of lifestyle choices, demographic shifts, medical issues, environmental influences, and genetic factors. Diseases like ischemic heart disease and hypertension, which fall under the umbrella of vascular heart diseases, can indirectly lead to mitral valve disease by negatively affecting the structure and function of the heart and consequentially impacting the mitral valve. For example, based on the Australian Bureau of Statistics 2020-21 data, the National Health Survey carried out by the Australia-based government agency, the Australian Institute of Health and Welfare, revealed that the mortality rate due to cardiovascular disease per 100,000 population jumped from 143.7 in 2021 to 148.2 in 2022 for males in Australia. Thus, the escalating incidence of vascular heart diseases is propelling the growth of the mitral valve disease market.

Request Your Free Mitral Valve Disease Market Report Sample Now!

https://www.thebusinessresearchcompany.com/sample.aspx?id=16480&type=smp

What Are the Major Players Making an Impact in the Mitral Valve Disease Market’s Growth?

Major companies operating in the mitral valve disease market are:

• Pfizer Inc._x000D_

• Bayer AG_x000D_

• Abbott Laboratories_x000D_

• Novartis AG_x000D_

• Medtronic plc_x000D_

Which Upcoming Trends Are Set to Influence the Mitral Valve Disease Market’s Path Forward?

Leading businesses in the mitral valve disease market are innovating stented tissue valves in response to the rising demand for less invasive treatment solutions. These valves are engineered to offer robust and dependable functionality, setting up an option to conventional surgical procedures. For example, Medtronic, a healthcare firm originating from Ireland, unveiled the Avalus Ultra valve in April 2024. This sophisticated surgical aortic tissue valve is crafted for improved implantation ease and extended patient care. Leveraging ten years of clinical know-how with the original Avalus valve, the Avalus Ultra is equipped with a low valve profile for simpler implantation, PEEK base frame for maintaining circular shape and a top-tier Effective Orifice Area (EOA) that could enhance blood circulation. Also included is a radiopaque coil, designed for unambiguous visibility during prospective valve-in-valve surgeries.

Pre-order Your Report for Quick and Easy Delivery!

https://www.thebusinessresearchcompany.com/report/mitral-valve-disease-global-market-report

Which Industry Segments Are Leading the Development and Expansion of the Mitral Valve Disease Market?

The mitral valve disease market covered in this report is segmented –

1) By Treatment Type: Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy, Mitral Valve Therapeutics

2) By Indication: Mitral Valve Stenosis, Mitral Valve Prolapse, Mitral Valve Regurgitation

3) By End-User: Hospitals, Ambulatory Surgical Centers, Other End-Users

Subsegments:

1) By Mitral Valve Repair: Surgical Repair, Minimally Invasive Repair, Percutaneous Mitral Valve Repair

2) By Mitral Valve Replacement: Mechanical Valve Replacement, Biological Valve Replacement, Transcatheter Mitral Valve Replacement (TMVR)

3) By Cardiac Resynchronization Therapy: Pacemaker Therapy, Implantable Cardioverter-Defibrillators (ICD), Biventricular Pacing

4) By Mitral Valve Therapeutics: Pharmacological Treatments, Anticoagulation Therapy, Mitral Valve Repair Devices

What Regions Are Steering Growth in the Mitral Valve Disease Sector?

Europe was the largest region in the mitral valve disease market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the mitral valve disease market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Are the Core Features That Define the Mitral Valve Disease Market?

Mitral valve disease is a disorder impacting the mitral valve, which controls blood movement between the heart’s left atrium and left ventricle. It can result in the valve becoming narrowed or leaky, disrupting normal blood flow and causing issues like breathlessness, tiredness, and abnormal heart rhythms. The primary aim of managing mitral valve disease is to ensure proper blood flow through the heart and to prevent complications.

Browse Through More Similar Reports By The Business Research Company:

Pigging Valves Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/pigging-valves-global-market-report

Aerospace Valves Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/aerospace-valves-global-market-report

Hygienic Pumps And Valves Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/hygienic-pumps-and-valves-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: